Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 01-Jul-21 5:32 PM View:  | Barber Jeffrey T Director | Pra Health Sciences, Inc. (PRAH) | 01-Jul-21 | Disposition | 14,729 | -- | -- | (100%) 14.73K to 0 | |
| 01-Jul-21 5:43 PM View: | Young Matthew P. Director | Pra Health Sciences, Inc. (PRAH) | 01-Jul-21 | Disposition | 7,127 | -- | -- | (100%) 7.13K to 0 | |
| 01-Jul-21 5:36 PM View: | Momtazee James C Director | Pra Health Sciences, Inc. (PRAH) | 01-Jul-21 | Disposition | 3,521 | -- | -- | (100%) 3.52K to 0 | |
| 01-Jul-21 6:26 PM View: | Shannon Colin President & CEO Director | Pra Health Sciences, Inc. (PRAH) | 01-Jul-21 | Disposition | 46,500 | -- | -- | (100%) 46.5K to 0 | |
| 01-Jul-21 5:33 PM View: | Dickinson Alexander George Director | Pra Health Sciences, Inc. (PRAH) | 01-Jul-21 | Disposition | 5,407 | -- | -- | (100%) 5.41K to 0 | |
| 01-Jul-21 5:47 PM View: | Bonello Michael J. EVP & CFO | Pra Health Sciences, Inc. (PRAH) | 01-Jul-21 | Disposition | 4,480 | -- | -- | (100%) 4.48K to 0 | |
| 01-Jul-21 6:29 PM View: | Gaenzle Christopher L EVP, CAO & General Counsel | Pra Health Sciences, Inc. (PRAH) | 01-Jul-21 | Disposition | 34,500 | -- | -- | (100%) 34.5K to 0 | |
| 01-Jul-21 5:34 PM View: | Grais Linda S Director | Pra Health Sciences, Inc. (PRAH) | 01-Jul-21 | Disposition | 9,683 | -- | -- | (100%) 9.68K to 0 | |
| 21-Jun-21 5:27 PM View: | Bonello Michael J. EVP & CFO | Pra Health Sciences, Inc. (PRAH) | 17-Jun-21 | Option Exercise | 52,551 | $87.41 | $4,593,690.00 | 443% 11.86K to 64.42K | |
| 21-Jun-21 5:27 PM View: | Bonello Michael J. EVP & CFO | Pra Health Sciences, Inc. (PRAH) | 17-Jun-21 | Market Option Sale (Planned) | 52,551 | $168.70 | $8,865,150.00 | (82%) 64.42K to 11.86K | < 1% |
| 21-Jun-21 5:28 PM View: | Gaenzle Christopher L EVP, CAO & General Counsel | Pra Health Sciences, Inc. (PRAH) | 17-Jun-21 | Market Option Sale (Planned) | 27,497 | $168.67 | $4,637,810.00 | (44%) 62.0K to 34.5K | < 1% |
| 21-Jun-21 5:25 PM View: | Shannon Colin President & CEO Director | Pra Health Sciences, Inc. (PRAH) | 17-Jun-21 | Option Exercise | 442,241 | $46.63 | $20,621,300.00 | 810% 54.63K to 496.87K | |
| 21-Jun-21 5:25 PM View: | Shannon Colin President & CEO Director | Pra Health Sciences, Inc. (PRAH) | 17-Jun-21 | Market Option Sale (Planned) | 442,241 | $168.76 | $74,634,096.00 | (89%) 496.87K to 54.63K | < 1% |
| 21-Jun-21 5:28 PM View: | Gaenzle Christopher L EVP, CAO & General Counsel | Pra Health Sciences, Inc. (PRAH) | 17-Jun-21 | Option Exercise | 27,497 | $100.88 | $2,773,790.00 | 80% 34.5K to 62.0K | |
| 17-Jun-21 8:50 PM View: | Gaenzle Christopher L EVP, CAO & General Counsel | Pra Health Sciences, Inc. (PRAH) | 16-Jun-21 | Market Sale (Planned) | 1,973 | $166.51 | $328,535.00 | (5%) 36.47K to 34.5K | (< 1%) |
| 17-Jun-21 8:21 PM View: | Shannon Colin President & CEO Director | Pra Health Sciences, Inc. (PRAH) | 16-Jun-21 | Option Exercise | 88,045 | $11.73 | $1,032,770.00 | 161% 54.63K to 142.67K | |
| 17-Jun-21 8:21 PM View: | Shannon Colin President & CEO Director | Pra Health Sciences, Inc. (PRAH) | 16-Jun-21 | Market Option Sale (Planned) | 77,728 | $166.49 | $12,940,900.00 | (54%) 142.67K to 64.94K | (< 1%) |
| 17-Jun-21 8:25 PM View: | Bonello Michael J. EVP & CFO | Pra Health Sciences, Inc. (PRAH) | 16-Jun-21 | Market Option Sale (Planned) | 7,213 | $166.47 | $1,200,720.00 | (25%) 29.08K to 21.87K | (< 1%) |
| 17-Jun-21 8:21 PM View: | Shannon Colin President & CEO Director | Pra Health Sciences, Inc. (PRAH) | 16-Jun-21 | Market Sale (Planned) | 10,317 | $166.49 | $1,717,670.00 | (16%) 64.94K to 54.63K | (< 1%) |
| 17-Jun-21 8:50 PM View: | Gaenzle Christopher L EVP, CAO & General Counsel | Pra Health Sciences, Inc. (PRAH) | 16-Jun-21 | Option Exercise | 14,278 | $100.88 | $1,440,310.00 | 41% 34.5K to 48.78K | |
| 17-Jun-21 8:50 PM View: | Gaenzle Christopher L EVP, CAO & General Counsel | Pra Health Sciences, Inc. (PRAH) | 16-Jun-21 | Market Option Sale (Planned) | 12,305 | $166.51 | $2,048,970.00 | (25%) 48.78K to 36.47K | (< 1%) |
| 17-Jun-21 8:25 PM View: | Bonello Michael J. EVP & CFO | Pra Health Sciences, Inc. (PRAH) | 16-Jun-21 | Option Exercise | 17,216 | $81.61 | $1,405,000.00 | 145% 11.86K to 29.08K | |
| 17-Jun-21 8:25 PM View: | Bonello Michael J. EVP & CFO | Pra Health Sciences, Inc. (PRAH) | 16-Jun-21 | Market Sale (Planned) | 10,003 | $166.47 | $1,665,160.00 | (46%) 21.87K to 11.86K | (< 1%) |
| 17-Jun-21 8:25 PM View: | Bonello Michael J. EVP & CFO | Pra Health Sciences, Inc. (PRAH) | 15-Jun-21 | Market Option Sale (Planned) | 31,126 | $168.28 | $5,238,020.00 | (72%) 42.99K to 11.86K | < 1% |
| 17-Jun-21 8:50 PM View: | Gaenzle Christopher L EVP, CAO & General Counsel | Pra Health Sciences, Inc. (PRAH) | 15-Jun-21 | Option Exercise | 12,615 | $100.88 | $1,272,550.00 | 35% 36.47K to 49.09K | |
| 17-Jun-21 8:50 PM View: | Gaenzle Christopher L EVP, CAO & General Counsel | Pra Health Sciences, Inc. (PRAH) | 15-Jun-21 | Market Option Sale (Planned) | 14,588 | $168.28 | $2,454,840.00 | (30%) 49.09K to 34.5K | < 1% |
| 17-Jun-21 8:25 PM View: | Bonello Michael J. EVP & CFO | Pra Health Sciences, Inc. (PRAH) | 15-Jun-21 | Option Exercise | 21,123 | $77.77 | $1,642,650.00 | 97% 21.87K to 42.99K | |
| 17-Jun-21 8:21 PM View: | Shannon Colin President & CEO Director | Pra Health Sciences, Inc. (PRAH) | 15-Jun-21 | Option Exercise | 132,986 | $11.73 | $1,559,930.00 | 205% 64.94K to 197.93K | |
| 17-Jun-21 8:21 PM View: | Shannon Colin President & CEO Director | Pra Health Sciences, Inc. (PRAH) | 15-Jun-21 | Market Option Sale (Planned) | 143,303 | $168.30 | $24,118,400.00 | (72%) 197.93K to 54.63K | < 1% |
| 03-Jun-21 4:02 PM View: | Gaenzle Christopher L EVP, CAO & General Counsel | Pra Health Sciences, Inc. (PRAH) | 01-Jun-21 | Market Sale | 850 | $170.45 | $144,882.00 | (2%) 37.32K to 36.47K | 1% |
| 03-Jun-21 4:04 PM View: | Momtazee James C Director | Pra Health Sciences, Inc. (PRAH) | 01-Jun-21 | Grant | 330 | -- | -- | 10% 3.19K to 3.52K | |
| 03-Jun-21 4:04 PM View: | Shannon Colin President & CEO Director | Pra Health Sciences, Inc. (PRAH) | 01-Jun-21 | Grant | 14,486 | -- | -- | 25% 56.93K to 71.41K | |
| 03-Jun-21 4:01 PM View: | Dickinson Alexander George Director | Pra Health Sciences, Inc. (PRAH) | 01-Jun-21 | Grant | 250 | -- | -- | 5% 5.16K to 5.41K | |
| 03-Jun-21 4:04 PM View: | Stettin Glen D. Director | Pra Health Sciences, Inc. (PRAH) | 01-Jun-21 | Grant | 250 | -- | -- | 31% 0.8K to 1.05K | |
| 03-Jun-21 4:03 PM View: | Bonello Michael J. EVP & CFO | Pra Health Sciences, Inc. (PRAH) | 01-Jun-21 | Grant | 4,823 | -- | -- | 25% 19.23K to 24.05K | |
| 03-Jun-21 4:04 PM View: | Shannon Colin President & CEO Director | Pra Health Sciences, Inc. (PRAH) | 01-Jun-21 | Market Sale | 6,470 | $170.45 | $1,102,810.00 | (9%) 71.41K to 64.94K | 1% |
| 03-Jun-21 4:02 PM View: | Gaenzle Christopher L EVP, CAO & General Counsel | Pra Health Sciences, Inc. (PRAH) | 01-Jun-21 | Grant | 2,823 | -- | -- | 8% 34.5K to 37.32K | |
| 03-Jun-21 4:03 PM View: | Grais Linda S Director | Pra Health Sciences, Inc. (PRAH) | 01-Jun-21 | Grant | 250 | -- | -- | 3% 9.43K to 9.68K | |
| 03-Jun-21 4:01 PM View: | Barber Jeffrey T Director | Pra Health Sciences, Inc. (PRAH) | 01-Jun-21 | Grant | 250 | -- | -- | 2% 14.48K to 14.73K | |
| 03-Jun-21 4:05 PM View: | Young Matthew P. Director | Pra Health Sciences, Inc. (PRAH) | 01-Jun-21 | Grant | 250 | -- | -- | 4% 6.88K to 7.13K | |
| 03-Jun-21 4:03 PM View: | Bonello Michael J. EVP & CFO | Pra Health Sciences, Inc. (PRAH) | 01-Jun-21 | Market Sale | 2,184 | $170.45 | $372,263.00 | (9%) 24.05K to 21.87K | 1% |
| 28-Apr-21 4:17 PM View: | Bonello Michael J. EVP & CFO | Pra Health Sciences, Inc. (PRAH) | 26-Apr-21 | Market Sale | 2,048 | $166.77 | $341,545.00 | (10%) 21.28K to 19.23K | (< 1%) |
| 11-Jan-21 4:26 PM View: | Gaenzle Christopher L EVP, CAO & General Counsel | Pra Health Sciences, Inc. (PRAH) | 08-Jan-21 | Market Sale (Planned) | 3,136 | $130.04 | $407,805.00 | (8%) 37.64K to 34.5K | (29%) |
| 18-Dec-20 4:15 PM View: | Bonello Michael J. EVP & CFO | Pra Health Sciences, Inc. (PRAH) | 17-Dec-20 | Option Exercise | 33,372 | $11.73 | $391,454.00 | 157% 21.28K to 54.65K | |
| 18-Dec-20 4:15 PM View: | Bonello Michael J. EVP & CFO | Pra Health Sciences, Inc. (PRAH) | 17-Dec-20 | Market Option Sale (Planned) | 33,372 | $120.12 | $4,008,640.00 | (61%) 54.65K to 21.28K | (40%) |
| 16-Sep-20 5:10 PM View: | Stettin Glen D. Director | Pra Health Sciences, Inc. (PRAH) | 14-Sep-20 | Grant | 799 | -- | -- | 100% 0 to 0.8K | |
| 17-Aug-20 4:18 PM View: | Shannon Colin President & CEO Director | Pra Health Sciences, Inc. (PRAH) | 13-Aug-20 | Market Sale | 6,073 | $102.88 | $624,790.00 | (10%) 63.0K to 56.93K | (63%) |
| 17-Aug-20 4:17 PM View: | Gaenzle Christopher L EVP, CAO & General Counsel | Pra Health Sciences, Inc. (PRAH) | 13-Aug-20 | Market Sale | 1,364 | $102.88 | $140,328.00 | (3%) 39.0K to 37.64K | (63%) |
| 17-Aug-20 4:17 PM View: | Bonello Michael J. EVP & CFO | Pra Health Sciences, Inc. (PRAH) | 13-Aug-20 | Market Sale | 2,052 | $102.88 | $211,110.00 | (9%) 23.33K to 21.28K | (63%) |
| 20-May-20 4:58 PM View: | Grais Linda S Director | Pra Health Sciences, Inc. (PRAH) | 18-May-20 | Grant | 1,324 | -- | -- | 16% 8.11K to 9.43K |
